PCRX
|
Pacira Pharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
PACB
|
Pacific Biosciences of California, Inc.
|
0.04%
|
US
|
NASDAQ
|
ONEM
|
1Life Healthcare, Inc.
|
0.04%
|
US
|
NASDAQ
|
OMCL
|
Omnicell, Inc.
|
0.04%
|
US
|
NASDAQ
|
ITGR
|
Integer Holdings Corporation
|
0.04%
|
US
|
NYSE
|
INSM
|
Insmed, Inc.
|
0.04%
|
US
|
NASDAQ
|
GKOS
|
Glaukos Corporation
|
0.04%
|
US
|
NYSE
|
FOLD
|
Amicus Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
ENOV
|
Enovis Corporation
|
0.04%
|
US
|
NYSE
|
CORT
|
Corcept Therapeutics Incorporated
|
0.04%
|
US
|
NASDAQ
|
CNMD
|
CONMED Corporation
|
0.04%
|
US
|
NYSE
|
BEAM
|
Beam Therapeutics Inc.
|
0.04%
|
US
|
NASDAQ
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
AXSM
|
Axsome Therapeutics, Inc.
|
0.04%
|
US
|
NASDAQ
|
AXNX
|
Axonics Modulation Technologies, Inc.
|
0.04%
|
US
|
NASDAQ
|
SEM
|
Select Medical Holdings Corporation
|
0.04%
|
US
|
NYSE
|
OSH
|
Oak Street Health, Inc.
|
0.04%
|
US
|
NYSE
|
EVH
|
Evolent Health, Inc
|
0.04%
|
US
|
NYSE
|
XNCR
|
Xencor, Inc.
|
0.03%
|
US
|
NASDAQ
|
XENE
|
Xenon Pharmaceuticals Inc.
|
0.03%
|
US
|
NASDAQ
|